Last news
New Data from Teva Shows Substantial Rates of Undertreated Tardive Dyskinesia in Long-Term Care Settings at Psych Congress Elevate 2025

New Data from Teva Shows Substantial Rates of Undertreated Tardive Dyskinesia in Long-Term Care Settings at Psych Congress Elevate 2025

Notified -...

Teva Presents Latest Schizophrenia Portfolio Data Including Real-World Outcomes with UZEDY® (risperidone) Showing Lower Rates of and Longer Time to Relapse Compared to Oral Treatment Options and New Phase 3 SOLARIS Data Showing No Incidence of PDSS with T

Teva Presents Latest Schizophrenia Portfolio Data Including Real-World Outcomes with UZEDY® (risperidone) Showing Lower Rates of and Longer Time to Relapse Compared to Oral Treatment Options and New Phase 3 SOLARIS Data Showing No Incidence of PDSS with T

Notified -...

‘Hong Kong Summer Viva’: Calling All Fans to Dive into Festivals, Games and Parties – Only in Hong Kong!

‘Hong Kong Summer Viva’: Calling All Fans to Dive into Festivals, Games and Parties – Only in Hong Kong!

Notified -...

D328eco® Test Aircraft Rolls Out: A Defining Milestone in Sustainable Regional Aviation

D328eco® Test Aircraft Rolls Out: A Defining Milestone in Sustainable Regional Aviation

Notified -...

YY Group Subsidiary, YY Circle and KFC Singapore Forge Strategic Partnership to Enhance Operational Excellence

YY Group Subsidiary, YY Circle and KFC Singapore Forge Strategic Partnership to Enhance Operational Excellence

Notified -...

Falcon Luxe Expands Private Jet Charter Offering with Block Hours Access

Falcon Luxe Expands Private Jet Charter Offering with Block Hours Access

Notified -...

Bitget Partners with Kronos Research to Deliver Institutional-Grade Liquidity and Trading Efficiency

Bitget Partners with Kronos Research to Deliver Institutional-Grade Liquidity and Trading Efficiency

Notified -...

Zymeworks Announces NMPA Approval of Zanidatamab in China for Adults with Previously Treated, Unresectable or Metastatic HER2-high expression (IHC3+) Biliary Tract Cancer

Zymeworks Announces NMPA Approval of Zanidatamab in China for Adults with Previously Treated, Unresectable or Metastatic HER2-high expression (IHC3+) Biliary Tract Cancer

Notified -...

1 ... 82 83 84 85 86 87 88 89 90 ... 883
menu
menu